result_id,cdm_name,group_name,group_level,strata_name,strata_level,variable_name,variable_level,estimate_name,estimate_type,estimate_value,additional_name,additional_level
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort start date,NA,q25,date,05-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort start date,NA,q25,date,30-07-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort start date,NA,q25,date,05-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort start date,NA,q25,date,30-07-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort start date,NA,median,date,12-03-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort start date,NA,median,date,18-09-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort start date,NA,median,date,12-03-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort start date,NA,median,date,18-09-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort start date,NA,q75,date,04-09-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort start date,NA,q75,date,29-08-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort start date,NA,q75,date,04-09-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort start date,NA,q75,date,29-08-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort end date,NA,min,date,30-11-11,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort end date,NA,min,date,30-11-11,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort end date,NA,q25,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort end date,NA,q25,date,08-03-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort end date,NA,q25,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort end date,NA,q25,date,08-03-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort end date,NA,median,date,15-10-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort end date,NA,median,date,15-01-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort end date,NA,median,date,15-10-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort end date,NA,median,date,15-01-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,overall,overall,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,overall,overall,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,overall,overall,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort start date,NA,min,date,27-01-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,min,date,27-01-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort start date,NA,min,date,27-01-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,min,date,27-01-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,min,date,28-11-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,min,date,28-11-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort start date,NA,min,date,20-10-11,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort start date,NA,min,date,20-10-11,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort start date,NA,q25,date,25-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,q25,date,29-04-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort start date,NA,q25,date,25-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,q25,date,29-04-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort start date,NA,q25,date,30-04-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,q25,date,05-07-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort start date,NA,q25,date,30-04-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,q25,date,05-07-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,q25,date,02-04-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,q25,date,02-04-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort start date,NA,q25,date,30-06-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort start date,NA,q25,date,30-06-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort start date,NA,median,date,15-09-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,median,date,10-06-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort start date,NA,median,date,15-09-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,median,date,10-06-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort start date,NA,median,date,17-10-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,median,date,26-12-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort start date,NA,median,date,17-10-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,median,date,26-12-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,median,date,01-11-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,median,date,01-11-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort start date,NA,median,date,16-07-16,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort start date,NA,median,date,16-07-16,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort start date,NA,q75,date,09-10-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,q75,date,23-05-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort start date,NA,q75,date,09-10-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,q75,date,23-05-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort start date,NA,q75,date,04-09-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,q75,date,26-08-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort start date,NA,q75,date,04-09-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,q75,date,26-08-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,q75,date,30-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,q75,date,30-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort start date,NA,q75,date,18-03-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort start date,NA,q75,date,18-03-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort start date,NA,max,date,22-11-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,max,date,22-11-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort start date,NA,max,date,22-11-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort start date,NA,max,date,22-11-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,max,date,05-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort start date,NA,max,date,05-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort start date,NA,max,date,05-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort start date,NA,max,date,05-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,min,date,31-07-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,min,date,31-07-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort end date,NA,min,date,30-11-11,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort end date,NA,min,date,30-11-11,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort end date,NA,q25,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,q25,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort end date,NA,q25,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,q25,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort end date,NA,q25,date,14-02-16,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,q25,date,29-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort end date,NA,q25,date,14-02-16,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,q25,date,29-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,q25,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,q25,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort end date,NA,q25,date,07-09-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort end date,NA,q25,date,07-09-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,median,date,16-05-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,median,date,16-05-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort end date,NA,median,date,31-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,median,date,15-01-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort end date,NA,median,date,31-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,median,date,15-01-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,0 to 17,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,18 to 39,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,40 to 59,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,60 to 79,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group,80 to 150,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort start date,NA,min,date,26-05-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort start date,NA,min,date,26-05-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort start date,NA,min,date,26-05-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort start date,NA,min,date,26-05-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort start date,NA,q25,date,13-08-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort start date,NA,q25,date,23-04-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort start date,NA,q25,date,13-08-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort start date,NA,q25,date,23-04-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort start date,NA,q25,date,01-10-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort start date,NA,q25,date,23-06-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort start date,NA,q25,date,01-10-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort start date,NA,q25,date,23-06-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort start date,NA,median,date,16-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort start date,NA,median,date,30-01-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort start date,NA,median,date,16-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort start date,NA,median,date,30-01-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort start date,NA,median,date,02-11-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort start date,NA,median,date,01-03-16,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort start date,NA,median,date,02-11-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort start date,NA,median,date,01-03-16,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort start date,NA,q75,date,09-06-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort start date,NA,q75,date,30-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort start date,NA,q75,date,09-06-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort start date,NA,q75,date,30-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort start date,NA,q75,date,28-07-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort start date,NA,q75,date,30-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort start date,NA,q75,date,28-07-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort start date,NA,q75,date,30-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort start date,NA,max,date,09-10-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort start date,NA,max,date,09-10-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort start date,NA,max,date,09-10-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort start date,NA,max,date,09-10-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort end date,NA,min,date,30-11-11,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort end date,NA,min,date,30-11-11,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort end date,NA,q25,date,08-12-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort end date,NA,q25,date,15-09-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort end date,NA,q25,date,08-12-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort end date,NA,q25,date,15-09-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort end date,NA,q25,date,22-09-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort end date,NA,q25,date,31-08-19,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort end date,NA,q25,date,22-09-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort end date,NA,q25,date,31-08-19,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort end date,NA,median,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort end date,NA,median,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort end date,NA,median,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort end date,NA,median,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort end date,NA,median,date,16-06-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort end date,NA,median,date,31-10-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort end date,NA,median,date,16-06-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort end date,NA,median,date,31-10-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort end date,NA,q75,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort end date,NA,q75,date,31-05-16,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort end date,NA,q75,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort end date,NA,q75,date,31-05-16,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,sex,Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,sex,Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,sex,Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Number records,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Number subjects,NA,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,min,date,27-01-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,min,date,27-01-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,min,date,22-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,min,date,22-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,min,date,22-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,min,date,22-02-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,min,date,02-02-10,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,min,date,28-11-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,min,date,28-11-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,min,date,20-10-11,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,min,date,20-10-11,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,q25,date,30-01-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,q25,date,30-01-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,q25,date,07-09-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,q25,date,10-06-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,q25,date,07-09-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,q25,date,10-06-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,q25,date,16-05-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,q25,date,09-07-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,q25,date,16-05-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,q25,date,09-07-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,q25,date,02-04-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,q25,date,02-04-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,q25,date,30-06-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,q25,date,30-06-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,median,date,05-03-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,median,date,05-03-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,median,date,12-10-16,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,median,date,21-05-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,median,date,12-10-16,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,median,date,21-05-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,median,date,26-10-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,median,date,11-02-16,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,median,date,26-10-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,median,date,11-02-16,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,median,date,01-11-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,median,date,01-11-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,median,date,16-07-16,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,median,date,16-07-16,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,q75,date,15-09-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,q75,date,15-09-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,q75,date,25-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,q75,date,11-08-20,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,q75,date,25-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,q75,date,11-08-20,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,q75,date,24-07-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,q75,date,04-12-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,q75,date,24-07-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,q75,date,04-12-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,q75,date,30-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,q75,date,30-01-19,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,q75,date,18-03-18,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,q75,date,18-03-18,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,max,date,09-10-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,max,date,09-10-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort start date,NA,max,date,08-12-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort start date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,max,date,22-11-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,max,date,22-11-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,max,date,22-11-22,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort start date,NA,max,date,22-11-22,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,max,date,05-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,max,date,05-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,max,date,05-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort start date,NA,max,date,05-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,min,date,31-03-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,min,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,min,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,min,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,min,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,min,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,min,date,31-12-12,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,min,date,31-07-15,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,min,date,31-07-15,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,min,date,30-11-11,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,min,date,30-11-11,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,q25,date,31-05-13,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,q25,date,31-05-13,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,q25,date,09-03-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,q25,date,24-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,q25,date,09-03-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,q25,date,24-07-21,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,q25,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,q25,date,31-05-16,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,q25,date,31-07-19,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,q25,date,31-05-16,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,q25,date,31-07-19,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,q25,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,q25,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,q25,date,07-09-17,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,q25,date,07-09-17,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,median,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,median,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,median,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,median,date,31-01-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,median,date,31-03-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,median,date,31-01-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,median,date,31-03-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,median,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,q75,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,q75,date,31-12-14,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,q75,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,q75,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Cohort end date,NA,max,date,NA,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Cohort end date,NA,max,date,31-12-23,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age group,0 to 17,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age group,18 to 39,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age group,40 to 59,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age group,60 to 79,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age group,80 to 150,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Age group,0 to 17,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Age group,18 to 39,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Age group,40 to 59,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Age group,60 to 79,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Age group,80 to 150,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Sex,Female,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Sex,Male,count,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Sex,Female,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Sex,Male,percentage,percentage,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Prior observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,min,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,q25,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,median,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,q75,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,max,integer,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,mean,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Future observation,NA,sd,numeric,0,overall,overall
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin ii receptor blockers arb drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Amiodarone drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Amiodarone drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Nitrofurantoin drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Methotrexate drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Methotrexate drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Ssr is and snri antidepressants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Statins drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Statins drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Thiazide diuretics drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Copd condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Copd condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Fluoroquinolones drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Cancer excluding non melanoma skin cancer condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Anticonvulsants drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Angiotensin converting enzyme ace inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Chemotherapy drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Gastro esophageal reflux disease condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Granulomatosis with polyangiitis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Hepatitis b and c condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Immune checkpoint inhibitors ic is drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Mammalian target rapamycin m tor inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Polymyositis or dermatomyositis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Pulmonary emphysema condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rheumatoid arthritis condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rituximab drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Rituximab drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sclerodermia condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sleep apnoea condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Sulphonamides drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Systemic lupus erythematosus condition,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tumor necrosis factor tnf alpha antagonists drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,count,integer,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,0 to 17 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,18 to 39 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,40 to 59 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Female,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,60 to 79 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_365_days_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_pulmonary_fibrosis_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,IPCI-20240430,cohort_name,ild_all_no_prior_observation,age_group &&& sex,80 to 150 &&& Male,Concepts flag -365 to 0,Tyrosine kinase inhibitors tk is including egfr inhibitors drug,percentage,percentage,0,window &&& value,-365 to 0 &&& flag
1,NA,overall,overall,overall,overall,settings,NA,package_name,character,CohortCharacteristics,overall,overall
1,NA,overall,overall,overall,overall,settings,NA,package_version,character,0.2.1,overall,overall
1,NA,overall,overall,overall,overall,settings,NA,result_type,character,summarise_characteristics,overall,overall
1,NA,overall,overall,overall,overall,settings,NA,min_cell_count,integer,0,overall,overall
